Global Hemostats Market to 2024 with Ethicon Dominating the $4.5 Bn Market
Comunicato Precedente
Comunicato Successivo
Global hemostats market is projected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.
Scope of the Report
Market Overview
Drivers
Restraints
Opportunities
Challenges
Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Premium Insights
5. Regulatory
6. Reimbursement
7. Executive Summary
8. Global Hemostats Market, by Type
9. Global Hemostats Market,By Application
10. Global Hemostats Market, by Distribution Channel
11. Global Hemostats Market, by End User
12. Global Hemostats Market, by Geography
13. Global Hemostats Market, Company Landscape
14. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/hvzbf4/global_hemostats
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
